Amberen Review 2026: Does It Work? What the Trials and Court Order Say

This Amberen review lands on a qualified maybe: the menopause capsules are a reasonable, tracked experiment for mild-to-moderate symptoms, not an answer proven for severe hot flashes. Two manufacturer-funded Russian trials support the capsule formula, but we found no independent replication. Walmart showed $24.97 for 30 days on September 2, 2026; the manufacturer’s refund window closes at day 60.

Best for you if

• Your symptoms are mild to moderate rather than repeatedly disrupting sleep, work, or daily life.
• You want a nonprescription option and understand that Amberen is a dietary supplement, not hormone therapy.
• You are close to the women actually studied: postmenopausal, ages 42 to 60.
• You will track a defined 90-day trial instead of drifting through months of “maybe.”
• You will save the receipt, photograph the lot code, and make the refund decision before day 60.

Not for you if

• Your hot flashes or night sweats are severe, soaking clothes or sheets, or regularly wrecking sleep. That population was not studied in the Amberen capsule trials.
• You have had any vaginal bleeding after 12 months without a period. That needs prompt medical evaluation, not a supplement experiment.
• You have severe hypertension, are pregnant, or are nursing. Current retail label information says not to use it in those situations.^[12]
• You have a hormone-sensitive cancer history and have not checked with your oncology clinician. The capsule trials excluded women with oncologic conditions, so they do not answer your safety or effectiveness question.^[3]
• You avoid MSG, gelatin, or carmine. All three appear in current ingredient information.^[12]

Amberen at a glance

Decision point	Amberen Menopause capsules	Equate “Compare to Amberen”	FDA-approved prescription options
What it is	Dietary supplement built around a proprietary succinate complex	Different dietary supplement built around KSM-66 ashwagandha	Drugs reviewed and approved by FDA for defined indications
Hormones in the product	No estrogen or progesterone	No estrogen or progesterone listed	Depends on treatment: Veozah and Lynkuet are nonhormonal; menopausal hormone therapy contains prescription hormones
Evidence population	Women ages 42–60 with mild-to-moderate postmenopausal symptoms	Amberen’s trials do not apply; it is a different formula	Veozah and Lynkuet were studied for moderate-to-severe vasomotor symptoms
Main outcome used	Greene Climacteric Scale, a 21-item overall symptom questionnaire	Separate ingredient evidence, not an Amberen-equivalence trial	Daily frequency and severity of moderate-to-severe hot flashes in phase 3 programs
Repeat testing of the exact product	No independent replication found in our search	No equivalence study to Amberen established here	Multiple registered phase 3 trials reviewed by FDA
The Menopause Society position	Ammonium succinate: Level II, not recommended	Supplements/herbal remedies: not recommended as a category	Several prescription and behavioral options are recommended
Verified cash price snapshot	$24.97 for 30 days at Walmart; $64.99 for 90 days on the captured Amazon offer	$18.58 for 30 days on the direct Walmart product capture	Prescription price and coverage depend on the drug, pharmacy, plan, and eligibility
How you get it	No prescription; sold through retailers	No prescription; sold at Walmart	Prescription and clinician evaluation required

The category line matters: Amberen is a supplement. It is not HRT, and it is not an FDA-approved treatment. Those categories have different evidence and regulatory standards. This page does not blur them.

Before you go further

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Where our money comes from, said plainly

We make money when some readers start care with telehealth providers we link to. We do not sell Amberen and do not earn anything if you buy it.

So here is something that costs us a click to tell you: if your symptoms are mild to moderate and you want a nonprescription option, a $25 first box—or a properly tracked $65-to-$75 full course—can be a reasonable experiment before you pay for care. If your symptoms are severe or disruptive, spending three months proving a supplement is not enough is the expensive choice.

We would rather you trust us in six months than click something today.

---

What is the verdict in this Amberen review?

Answer: Amberen Menopause capsules have product-specific randomized evidence, but it is narrower than the front of the box makes it feel. Two manufacturer-funded, 90-day Russian trials found symptom-score improvements in women with mild-to-moderate symptoms. No independent replication was located, published controlled evidence does not establish long-term benefit or safety, and The Menopause Society does not recommend ammonium succinate for hot flashes.^[2][3][5]

That makes the verdict a qualified maybe, not a yes for everyone and not a dismissal.

The woman closest to the evidence is postmenopausal, 42 to 60, dealing with symptoms that are frustrating but not life-stopping, and willing to run a defined trial with a stopping rule. The woman furthest from the evidence is having severe or highly disruptive symptoms, has a medical history the trials excluded, or needs a treatment supported by multiple phase 3 trials and FDA review.

That is the line the marketing does not draw for you. This page will.

---

What is Amberen, and is it the same as HRT?

Answer: Amberen is an over-the-counter dietary supplement. It contains no estrogen or progesterone and is not hormone replacement therapy. Menopausal hormone therapy is prescription treatment—usually estrogen, with a progestogen generally added when a woman has a uterus—whereas Amberen is a proprietary blend of succinate and fumarate salts, glycine, monosodium L-glutamate, zinc, and vitamin E.^{[1][5][6][12]}

The distinction is not cosmetic.

FDA reviews a new drug application before an approved drug can be marketed for a specific use. Dietary supplements generally do not receive FDA premarket approval for safety or effectiveness. The manufacturer is responsible for ensuring the supplement is lawful and properly labeled; FDA can take action after marketing when a product is unsafe, adulterated, misbranded, or otherwise violates the law.^[6]

Amberen’s current product page describes its capsule formula as a proprietary complex of “adaptogenic succinates,” amino acids, and vitamin E. The current ingredient feed we verified lists ammonium succinate, calcium disuccinate, monosodium L-glutamate, glycine, magnesium disuccinate, zinc difumarate, and tocopheryl acetate, with gelatin and other inactive ingredients.^[1][12]

The manufacturer proposes that the formula supports “hormone balance.” The clinical trials measured symptoms and selected laboratory values; they did not establish a proven mechanism that makes the supplement equivalent to replacing estrogen. No hormones in the capsule and proven not to affect hormone biology are not the same claim.

---

Does Amberen actually work for menopause symptoms?

Answer: In the 2019 pooled analysis of two trials, 227 women were included in the analysis and the active group improved more than placebo on 16 of 21 Greene Climacteric Scale symptoms over 90 days. That is a real randomized, double-blind, placebo-controlled result. It is also manufacturer-funded evidence from one country, in women with mild-to-moderate symptoms, and we found no independent replication.^[3]

The useful answer depends on where you sit relative to that study population.

If your symptoms are mild to moderate and fluctuate, Amberen may be worth a tracked trial. If hot flashes and night sweats repeatedly wake you, soak clothing or bedding, or interfere with work and daily function, the capsule trials do not show that Amberen is enough for you.

The difference matters because placebo response in vasomotor-symptom trials can run from roughly 20% to 66%. Symptoms also vary naturally over time. That is why a good week, a friend’s story, or a star rating cannot tell you what a controlled comparison can—and why your own trial needs a baseline rather than a vague memory.^[5]

This is not us calling the Amberen evidence fake. It is narrow. Narrow evidence can still be useful when you know whether you are inside its lines.

The one question to answer before you buy

Ask yourself: Are these symptoms annoying, or are they now controlling my sleep, work, or day?

• If they are annoying but manageable, a measured supplement trial may fit.
• If they are controlling your life, use Find My HRT Path or compare verified online menopause-care options instead of donating another season to guesswork.

---

What did the Amberen clinical trials really test?

Answer: The postmenopause capsule evidence comes from two underlying randomized trials—not three. A 2016 English-language paper reported one 125-participant trial. A 2019 paper pooled that trial with an earlier, nearly identical 104-participant trial reported separately in Russian; it reanalyzed the same two studies rather than adding a third. A 2024 trial tested Amberen with Smart B in perimenopause, so it cannot be counted as another trial of the menopause capsules alone.^{[2][3][4][20]}

The Amberen evidence ledger

Publication or trial	What it actually represents	Participants	Population and setting	Main measures	Funding and conflicts	What it can support
Underlying trial 1, reported by Kuznetsova et al. in 2016	First randomized, double-blind, placebo-controlled, 90-day capsule trial later included in the pooled paper	104 randomized	Postmenopausal women 42–60 at three Russian sites; mild-to-moderate symptoms	Greene Climacteric Scale, anxiety, selected laboratory measures	The pooled paper states Biogix funded both trials and supplied active and placebo product	One of the two short-term studies behind the pooled result—not an additional third trial
Underlying trial 2, Radzinskii et al., 2016	Second randomized, double-blind, placebo-controlled, 90-day capsule trial	125 randomized	Postmenopausal women 42–60 at three Russian sites; mild-to-moderate symptoms	Greene Climacteric Scale and anxiety measure	Industry funded; the pooled paper states the manufacturer funded and supplied products	Short-term symptom-score findings for the studied menopause capsule population
Radzinsky et al., 2019	Pooled reanalysis of the 104-person and 125-person trials	227 analyzed: 114 active, 113 placebo	Postmenopausal women 42–60 at Russian sites; mild-to-moderate symptoms	Greene Climacteric Scale, anxiety, selected laboratory measures	Biogix funded the trials and supplied active and placebo product; a paid consultant and company manuscript support were disclosed	Combined estimate across the same two underlying capsule trials—not a third trial
Kachko et al., 2024	Separate randomized trial of Amberen plus Smart B	106 enrolled; 105 completed	Perimenopausal women up to age 50 with uncomplicated mild-to-moderate symptoms	Greene scale, STAI, HADS, well-being/activity/mood	Biogix funded the trial; Alliance funded publication fees; an Alliance scientific adviser and consultant were authors	Evidence for the perimenopause combination studied, not menopause capsules alone

The 2016 paper reported statistically significant improvement versus placebo on 13 of 21 Greene symptoms. The 2019 pooled analysis reported improvement on 16 of 21 symptoms and lower anxiety scores.^[2][3]

The pooled paper also states its most important limits plainly: the women were of Russian ancestry, the work was short term, and broader and longer research was needed. The 2024 trial adds perimenopause data, but it does not fix the independence problem: it was also manufacturer funded and tested a combination formula.^[3][4]

What the current product page cites

Amberen’s current menopause-capsule page does not describe five modern capsule trials. Its footnote points to a 90-day placebo-controlled study of 125 women with mild-to-moderate symptoms. The same footnote says the menopause gummies rely on a trial in which the proprietary blend was given in capsule form.^[1]

That is why this review counts the evidence this way:

• Two underlying postmenopause capsule trials.
• One pooled reanalysis of those same two trials.
• One separate perimenopause combination trial.
• No independent replication found in our search.

The endpoint comparison nobody should skip

Evidence question	Amberen capsule trials	Veozah and Lynkuet development programs
Symptom severity enrolled	Mild to moderate	Moderate to severe vasomotor symptoms
Primary style of measurement	Overall symptom severity on the 21-item Greene Climacteric Scale	Frequency and severity of moderate-to-severe vasomotor symptoms recorded over time
Core controlled period	90 days	12-week efficacy trials, with additional safety follow-up in development programs
Independent regulatory review	No FDA premarket efficacy review for the supplement	Full drug applications reviewed by FDA
Independent replication of exact product	None located	Multiple phase 3 trials within each drug’s program

Amberen’s studies asked a broad question: did an overall menopause-symptom score improve? The FDA drug programs had to answer a narrower one in a more severe population: how many moderate-to-severe hot flashes occurred, and how bad were they?

Those are not interchangeable endpoints. That does not erase Amberen’s result. It tells you exactly how far the result travels.

What The Menopause Society says

The Menopause Society reviewed ammonium succinate directly in its 2023 nonhormone position statement. It described the studies as identical 90-day, double-blind trials with manufacturer-sponsored evidence, noted the pooled 227-woman result, and concluded that ammonium succinate was not recommended, Level II, because the evidence was limited and manufacturer sponsored.^[5]

The same statement recommends cognitive behavioral therapy, clinical hypnosis, SSRIs/SNRIs, gabapentin, and fezolinetant at Level I; oxybutynin at Levels I–II; and weight loss and stellate ganglion block at Levels II–III. Supplements and herbal remedies are not recommended as a category for vasomotor symptoms.^[5]

That is the fairest way to hold both facts at once: Amberen has controlled trials, and the specialty society still does not recommend it.

---

Is Amberen FDA approved?

Answer: No. Amberen is a dietary supplement, not an FDA-approved menopause drug. FDA does not approve dietary supplements for safety and effectiveness before they are marketed in the way it approves new drugs. The required supplement disclaimer on Amberen’s page says its statements have not been evaluated by FDA and the products are not intended to diagnose, treat, cure, or prevent disease.^[1][6]

“Clinically tested,” “clinically proven,” and “FDA approved” mean different things.

• Clinically tested means a study was conducted or cited.
• Clinically proven is an advertising claim that still has to be supported and not misleading.
• FDA approved means FDA reviewed a drug application and approved the product for a specific use under specific labeling.

Amberen’s controlled trials are real documentation. They do not turn it into an approved drug, establish equivalence to HRT, or place its claims under the same premarket review as Veozah, Lynkuet, estradiol, progesterone, or other prescription treatments.

---

Why is there a 2016 federal court order connected to Amberen?

Answer: In May 2016, a federal court entered a permanent injunction and monetary judgment resolving FTC allegations against Lunada Biomedical and related defendants over Amberen weight-loss, menopause-relief, endorsement, satisfaction-rate, and “risk free” advertising. The defendants did not admit or deny the allegations except as stated for jurisdiction. The order set specific evidence and disclosure rules for the defendants and, by its terms, their successors and assigns.^[7][8]

That distinction matters: the FTC complaint contained allegations; the signed order contains the obligations the defendants agreed to.

What the FTC alleged

The FTC alleged that Lunada advertised Amberen as causing substantial weight loss, belly-fat loss, and increased metabolism in women over 40 without adequate support. It also challenged broad menopause-relief claims, a claimed 93% success or satisfaction figure, undisclosed endorser relationships, and a “risk free” offer whose material return restrictions were not made clear.^[8]

The FTC reported that nearly $65 million of Amberen had been sold from 2010 through 2013. The order entered a $40 million judgment and suspended the balance after a $250,000 payment, subject to its terms.^[7][8]

That history is not proof that the current product never helps anyone. It is proof that the exact wording of the evidence claim matters.

What the order requires

For the listed weight-loss and menopause claims, the order requires nonmisleading representations supported by competent and reliable scientific evidence. For those claims, the order defines that evidence as human clinical testing of the covered product or an essentially equivalent product, with randomized, double-blind, placebo-controlled testing among the requirements.^[7]

It also bars misrepresenting study results, scientific proof, success or customer-satisfaction rates, and material terms of an offer. It requires clear disclosure of material connections with endorsers.^[7]

The HRT Index claim–order map

On September 2, 2026, Amberen’s current capsule page listed 12 symptom claims. We mapped each one to the symptom language in Section I.E of the court order.^[1][7]

Current Amberen capsule-page claim	Corresponding language in the 2016 order	Match
Hot flashes	Hot flashes	✓
Night sweats	Night sweats	✓
Fatigue	Lack of energy	✓
Mood swings	Mood swings	✓
Weight gain	Weight gain	✓
Difficulty sleeping	Sleeplessness	✓
Irritability	Irritability	✓
Stress	Stress	✓
Low libido	Decreased libido	✓
Joint aches	Muscle or joint aches	✓
Headaches	Headache	✓
Difficulty concentrating	Inability to concentrate	✓

Twelve out of twelve current symptom claims overlap with the symptom list in the order.

We are not saying the current owner is violating the order. The order allows supported, nonmisleading claims, and Amberen has randomized controlled evidence. The point is narrower and more useful: the company’s present claims sit inside the exact territory where study design, product identity, population, endpoint, and advertising precision matter.

Alliance Pharma acquired Biogix and the Amberen brand in 2020 for $110 million. Current product pages identify Alliance and send buyers to retailer checkout.^[1][19]

You now know what the front of the box does not tell you: the existence of a trial is only the beginning of the question.

---

What is actually in Amberen?

Answer: Current ingredient information lists ammonium succinate, calcium disuccinate, monosodium L-glutamate, glycine, magnesium disuccinate, zinc difumarate, and vitamin E, with gelatin, rice flour, magnesium stearate, silicon dioxide, titanium dioxide, riboflavin, carmine, and water among the inactive ingredients. The non-vitamin ingredients are presented as a proprietary complex, so the amount of each component is not disclosed.^[12]

Ingredient	What it is	What the label comparison means for you
Ammonium succinate	A succinate salt	Central named ingredient in the studied complex
Calcium disuccinate	Calcium bound to succinate	Part of the proprietary complex
Monosodium L-glutamate	MSG	Listed ingredient; skip if you choose to avoid MSG
Glycine	Amino acid	Part of the proprietary complex
Magnesium disuccinate	Magnesium bound to succinate	Part of the proprietary complex
Zinc difumarate	Zinc bound to fumarate	Part of the proprietary complex
Vitamin E / tocopheryl acetate	Antioxidant vitamin	Listed separately in current retailer nutrition data
Gelatin	Animal-derived capsule material	Product is not vegan or vegetarian
Carmine	Insect-derived coloring	Product is not vegan or vegetarian
Titanium dioxide	Coloring agent	Present in current ingredient information

Three practical facts do more work than the ingredient marketing:

1. MSG is not hidden, but it surprises people. If you avoid it, know before you buy.
2. A proprietary blend blocks dose-by-dose comparison. You can see the ingredient list, but not the amount of each component.
3. The capsule is not vegan or vegetarian. Gelatin and carmine decide that question.

Retailer data feeds have displayed inconsistent total-blend figures, so this page does not publish a total proprietary-blend amount as if it were settled. The ingredient identities above were consistent in the current source we verified.^[12]

---

Does Amberen have side effects or safety concerns?

Answer: The pooled postmenopause trials reported no serious adverse events during 90 days, while the 2024 perimenopause combination trial reported a few mild, transient adverse effects. That is short-term evidence, not a long-term safety record. Current retail label information says not to use Amberen with severe hypertension, during pregnancy, or while nursing, and to consult a clinician when taking prescription medication or managing a medical condition.^[3][4][12]

The phrase “no reported serious adverse events” is accurate for the studied period. “No side effects” is too broad.

The long-term gap is real

The controlled capsule evidence runs for 90 days. It does not answer what happens after years of daily use, whether rare effects emerge in a much larger population, or whether the risk-benefit balance changes with age, new diagnoses, or new medications.^[3]

That gap does not prove long-term harm. It means long-term reassurance has not been earned by the published trials.

“Hormone-free” describes the ingredients, not a proven biological non-effect

Amberen contains no estrogen or progesterone. That part is straightforward.

The 2019 pooled paper also reported an increase in serum estradiol from baseline in the active group. But the groups differed at baseline for some laboratory values, and the paper did not establish a clinically meaningful hormone effect versus placebo or a mechanism equivalent to estrogen treatment.^[3][5]

So do not turn that laboratory finding into either of these unsupported claims:

• “Amberen works like estrogen.”
• “Amberen is guaranteed not to affect any hormone-related pathway.”

The honest conclusion is smaller: the capsule contains no hormones, and the available trial does not settle every downstream hormonal question.

A cancer history changes the decision

The capsule trials excluded women with oncologic conditions. That means the evidence cannot tell a breast-cancer survivor, or someone taking endocrine therapy, that the product is proven safe or effective for her situation.^[3]

If that is you, ask the oncology clinician or pharmacist who knows your diagnosis and medications. “Over the counter” is not the same as “no conversation needed.”

Bleeding after menopause is not a supplement question

Any vaginal bleeding after 12 months without a period needs prompt medical evaluation.

That rule does not depend on whether bleeding began before or after a supplement. ACOG advises women with bleeding after menopause to see an obstetrician-gynecologist for evaluation.^[14]

Most explanations are not cancer. Some are. Either way, waiting to see whether a supplement “settles” it is the wrong test.

Current retailer-displayed cautions

• Do not use if you have severe hypertension.
• Do not use if pregnant or nursing.
• Ask a clinician or pharmacist before use if you take prescription medication or have a medical condition.
• Stop and seek medical advice for a concerning reaction or new symptom.

---

How long does Amberen take to work?

Answer: The current brand page says users may notice changes beginning around day 30 and presents a 30-, 60-, and 90-day symptom timeline. Its evidence footnote is based on a 90-day trial. That is a full season of symptoms and $64.99 to $74.91 at the verified purchase paths—not a casual one-week test.^[1][10][11]

Ninety days is long enough for symptoms to fluctuate and memory to rewrite the starting point. Without a baseline, you can reach day 90 honestly unable to tell whether anything changed.

The 90-day stopping rule

Before day 1: Record seven baseline days. Track hot flashes, night sweats, sleep interruptions, the worst daily symptom score, and how much symptoms interfered with normal life.

Day 30: Compare the previous seven days with baseline. The brand says this is when some changes may begin. “I think maybe” is not a result; look for a pattern you can name.

Day 50–55: Make the refund decision while time remains to gather the receipt, lot code, and package information. Do not wait until the last day.

Day 60: The manufacturer’s claim window closes. That is the commercial deadline, not the end of the brand’s 90-day timeline.^[9]

Day 90: Ask one clean question: If I stopped tomorrow, would I expect to notice? If the answer is no—or you still cannot tell—the experiment gave you an answer.

No published controlled evidence tells you how long to remain on Amberen after 90 days. Continuing indefinitely without periodically testing whether it still earns its place is not a plan. It is autopilot.

---

How much does Amberen cost in 2026?

Answer: On September 2, 2026, Walmart showed $24.97 for a 30-day, 60-count box sold and shipped by Walmart.com. Amazon’s captured variants showed one offer from $24.97 for 30 days, $44.99 for 60 days, and $64.99 for 90 days; the captured 90-day offer was sold by Alliance Pharma Inc. Prices and sellers can change, so verify both at checkout.^[10][11]

Seller and captured offer	Supply	Captured price	Cost per day	Seller or return detail
Amazon, 90-day variant	180 capsules / 90 days	$64.99	$0.72	Captured offer sold by Alliance Pharma Inc; recheck the “Sold by” line
Amazon, 60-day variant	120 capsules / 60 days	$44.99	$0.75	One offer shown; recheck seller at checkout
Amazon, 30-day variant	60 capsules / 30 days	$24.97	$0.83	One offer shown; recheck seller at checkout
Walmart.com direct	60 capsules / 30 days	$24.97	$0.83	Sold and shipped by Walmart.com; listing showed free 90-day returns
H-E-B	60 capsules / 30 days	$24.97	$0.83	Local stock and store pricing can vary

The number that should change how you buy

Three $24.97 boxes cost $74.91 for 90 days. The captured Amazon 90-day offer cost $64.99.

That is $9.92 saved, not the $33 suggested by stale Amazon pricing in earlier captures. It is useful, but it is not a half-price miracle.

The seller line matters as much as the price. A cheap marketplace listing can fall outside the manufacturer guarantee. Do not assume the product title tells you who sold it.

If $65 to $75 is already in your budget

Pause before treating that number as “just a supplement.” If your symptoms are mild and you want the nonprescription route, the trial can make sense. If symptoms are already costing you sleep, focus, or functioning, that same budget may be better used toward an evaluation and a treatment chosen for your severity.

Compare verified online menopause-care options when the supplement aisle no longer matches the size of the problem.

---

Does Amberen’s 60-day guarantee cover its 90-day timeline?

Answer: The guarantee does not remain open through day 90. Alliance requires a claim within 60 calendar days of purchase, while Amberen’s product page presents results across a 90-day timeline. The guarantee also requires proof of purchase and package information, makes the buyer pay mailing costs, and applies marketplace-specific seller rules.^[1][9]

That creates a 30-day refund gap.

The refund timeline

Day	What to do	Why it matters
0	Save the receipt; photograph the seller, box, and lot code	The guarantee requires proof and package identification
1–7	Record baseline symptoms	You cannot measure a change you never documented
30	Compare the last seven days with baseline	The brand says results may begin around this point
50–55	Decide whether to claim and assemble the required material	Leaves time before the 60-calendar-day deadline
60	Manufacturer claim window closes	Waiting for day 90 forfeits this route
90	Complete the full personal review if you continued	This is the brand’s endpoint, after the guarantee has closed

Put day 55 in your phone when you buy it. That thirty seconds may matter more than another hour reading reviews.

The seller rule that can decide the refund

Alliance’s guarantee says:

• You must first try to resolve the issue with the authorized seller.
• Amazon purchases qualify only when the product is sold by Alliance Pharma Inc.
• Alliance says it has no authorized sellers on other online marketplaces, including eBay and Walmart Marketplace.
• Proof of purchase and a piece of the packaging showing the lot number are required; the company may request photographs or unused product.
• You pay the mailing cost.
• The policy applies to original end-user purchasers in the United States and can be changed or ended by Alliance.^[9]

A Walmart.com item sold and shipped by Walmart.com is not the same thing as a third-party Walmart Marketplace listing. Walmart’s retailer return policy is also separate from Alliance’s manufacturer guarantee. Save the receipt either way.^[11]

---

The Amberen 90-day trial tracker

Answer: A useful Amberen trial needs a baseline, a fixed set of measures, a refund checkpoint before day 60, and a final stop/continue decision at day 90. The tracker below turns “maybe it helped” into a record you can actually use. It does not diagnose anything or replace medical care.

Track the same five measures each time

1. Hot flashes per day.
2. Night sweats per week.
3. Sleep interruptions per night.
4. Worst symptom intensity from 0 to 10.
5. Interference with sleep, work, exercise, or normal plans from 0 to 10.

Checkpoint	Hot flashes/day	Night sweats/week	Wakeups/night	Worst symptom 0–10	Life interference 0–10	New symptoms or side effects	Decision
Baseline week							Start only if this is still the right lane
Day 30							Continue, stop, or ask for advice
Day 50–55							Refund decision before day 60
Day 60							Claim window closes
Day 90							Continue deliberately or stop

Stop the experiment and get medical help instead when

• Vaginal bleeding occurs after 12 months without a period.
• Symptoms become severe, frightening, or rapidly worse.
• You develop a concerning reaction.
• A clinician or pharmacist advises against combining it with your condition or medication.
• The cost of waiting is now showing up in sleep, work, driving, mood, or daily functioning.

This tracker is not designed to make you stay on the product. It is designed to stop indecision from becoming a subscription.

---

Is Walmart’s “Compare to Amberen” product the same formula?

Answer: No. Walmart’s Equate Multi-Symptom Menopause Formula says “Compare to the Benefits of Amberen,” but the direct product page identifies KSM-66 ashwagandha as its clinically tested ingredient. Amberen uses a succinate-based proprietary complex. The two products do not share the active formula studied in Amberen’s trials.^[12][13]

Comparison	Amberen Menopause capsules	Equate Multi-Symptom Menopause Formula
Core formula	Succinate/fumarate salts, glycine, MSG, zinc, vitamin E	KSM-66 ashwagandha-led formula with vitamins
Product-specific Amberen capsule evidence	Yes, within the limits described above	No—the Amberen trials do not transfer
Ingredient category	Mineral salts, amino acid, vitamin	Botanical extract plus vitamins
Direct Walmart price captured	$24.97 for 30 days	$18.58 for 30 days
Shared active formula	No	No

A “compare to” dietary-supplement label does not make the product an ingredient-equivalent version of Amberen. It is a benefits comparison, not proof that the contents match.

If you specifically want the succinate formula from the Amberen studies, Equate is not it. If you want an ashwagandha product, that is a separate decision with separate evidence.

---

Which Amberen product did the research study?

Answer: The postmenopause trials studied the succinate-based capsule formula. The 2024 perimenopause trial studied Amberen with Smart B. The current menopause-gummy page relies on a trial where the proprietary blend was administered in capsule form. The broader Amberen line includes targeted products that are not the studied menopause capsule and should not inherit its evidence automatically.^[1][4]

Current product line	What the cited evidence applies to
Amberen Menopause capsules	The two underlying 90-day postmenopause capsule trials apply, with their population and funding limits
Amberen Perimenopause capsules	Separate 2024 evidence for Amberen plus Smart B in mild-to-moderate perimenopause
Amberen Menopause gummies	The brand cites a study using the proprietary blend in capsule form; the finished gummy was not the dosage form used in that cited trial
Keep Cool	Different targeted product; do not transfer the capsule trials
Libido Spark	Different targeted product; do not transfer the capsule trials
Keep Agile	Different targeted product; do not transfer the capsule trials
Find Focus	Different targeted product; do not transfer the capsule trials

The brand name has stretched past the thing that was tested. That is common in supplement lines, and it is exactly where shoppers can transfer evidence farther than it goes without anyone stating a technically false sentence.

If you want the product with the direct postmenopause evidence, choose the menopause capsules—not a different Amberen product because the logo matches.

---

What do Amberen customer reviews actually tell you?

Answer: Retail ratings show that many buyers report being satisfied with the product or purchase experience, but they cannot establish medical effectiveness. At the September 2, 2026 capture, Amazon showed 4.2 out of 5 from about 24,000 reviews, and Walmart showed 4.5 from about 1,500. Those are useful shopping signals, not controlled evidence.^[10][11]

Retailer snapshot	Rating	Review count	What it can tell you	What it cannot tell you
Amazon	4.2 / 5	About 24,000	Buyer satisfaction on that listing	Whether symptoms improved beyond placebo or natural fluctuation
Walmart	4.5 / 5	About 1,500	Satisfaction among buyers on that listing	Whether the product works for severe symptoms or excluded medical histories

We are not averaging those into a proprietary star score. A single number would create precision the evidence does not have.

A good retail review can warn you about capsule size, shipping, packaging, or customer service. It cannot tell you whether a symptom change was caused by the product. That is what randomization and placebo control are for.

---

Is Amberen being discontinued?

Answer: We found no current evidence that Amberen is being discontinued. The official site was active on September 2, 2026, displayed a current product catalog, maintained the menopause-capsule page, and directed buyers to Amazon. Walmart, Amazon, and H-E-B also had active listings.^{[1][10][11][12]}

What has changed is the purchase path: the official website describes itself as a reference site and sends shoppers to third-party retailers rather than presenting a first-party checkout.^[1]

That is not the same as discontinuation.

If you see a seller using “last chance,” “hard to find,” or similar urgency, check the official catalog and direct retailer stock before paying a markup. The current evidence supports still sold through retailers, not being phased out.

---

What works better than Amberen when it is not enough?

Answer: For bothersome vasomotor symptoms, hormone therapy remains the most effective treatment when it is medically appropriate. Evidence-supported nonhormonal options include cognitive behavioral therapy, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant, oxybutynin, weight loss, and stellate ganglion block at different evidence levels. Elinzanetant is also now FDA approved for moderate-to-severe vasomotor symptoms.^{[5][15][16][17]}

You have not run out of choices because you do not want—or cannot use—hormones.

The nonhormonal prescription lane

Veozah (fezolinetant) is FDA approved for moderate-to-severe vasomotor symptoms. FDA added a boxed warning for rare but serious liver injury. Current monitoring includes liver tests before treatment, monthly for the first three months, and again at months 6 and 9.^[15]

Lynkuet (elinzanetant) was FDA approved on October 24, 2025, for moderate-to-severe vasomotor symptoms. Its current labeling includes liver testing and central-nervous-system cautions; it does not carry Veozah’s boxed warning.^[16][17]

SSRIs/SNRIs, gabapentin, and oxybutynin also have evidence and require a prescription conversation. “Nonhormonal” does not mean “risk free,” but it also does not mean “supplement only.”

The non-drug lane

Cognitive behavioral therapy and clinical hypnosis are Level I recommendations in The Menopause Society statement. Weight loss is recommended at a lower evidence level for women for whom it is relevant. These options are not consolation prizes, and their recommendation strength exceeds the supplement category.^[5]

The hormone-therapy lane

Hormone therapy remains the most effective treatment for vasomotor symptoms and may be appropriate depending on age, time since menopause, symptoms, medical history, route, and personal preference.^[5]

In February 2026, FDA approved labeling changes for six menopausal hormone-therapy products that removed certain boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia. That did not erase every warning, change every product, or make hormone therapy right for everyone.^[18]

Read the benefits and risks of HRT for the decision framework, or use our nonhormonal-options guide if estrogen is not your lane.

If your symptoms have outgrown the supplement aisle

Does this sound like your situation: symptoms most days, sleep or concentration already paying the price, and no appetite for spending three months proving that a bottle is not enough?

Then the next step is not another supplement. It is a clinician who can evaluate treatments studied at your severity, including FDA-approved hormonal and nonhormonal options.

Compare the best verified online HRT providers for menopause—including medication models, insurance, cash pricing, and the situations that need in-person care first.

---

Who should try Amberen, and who should skip it?

Answer: Amberen is a defensible, time-limited experiment for a postmenopausal woman with mild-to-moderate symptoms who wants a nonprescription option and will track the result. It is a poor use of time for severe or highly disruptive symptoms, and it cannot answer safety questions for populations excluded from the trials. Postmenopausal bleeding bypasses the supplement decision entirely.^[3][14]

Find yourself here.

If symptoms are mild and come and go

A reasonable thing to try. You are closest to the women studied. Buy from a seller whose identity you can verify, save the receipt and lot code, record a baseline week, and set day 55 before you swallow the first dose.

The downside is not just the purchase price. It is the possibility of drifting for months without knowing whether the product earned another box. The tracker fixes that.

If symptoms are moderate but still manageable

Reasonable, with a hard deadline. You are near the upper edge of the studied population. Define what improvement must look like and do not quietly lower the standard because you already paid.

If symptoms are severe or repeatedly wreck sleep

Skip it, and we would rather lose the click than waste your autumn. The Amberen capsule trials did not study severe symptoms. Treatments with evidence in moderate-to-severe vasomotor symptoms belong higher on your list.

If you have a hormone-sensitive cancer history

Ask your oncology clinician first. The trials excluded oncologic conditions. “No hormones in the capsule” does not fill that evidence gap.

If you have severe hypertension, are pregnant, or are nursing

Skip it. Those situations are named in current retail label information.^[12]

If you are bleeding after 12 months without a period

This is not a supplement decision. Contact a clinician promptly.^[14]

The honest bottom line

Amberen has two direct randomized capsule trials. It is also studied narrowly: two short manufacturer-funded trials, one country, one broad symptom scale, women with mild-to-moderate symptoms, and no independent replication.

For the woman inside those lines, it is a $64.99-to-$74.91 experiment with a defined ending.

For the woman outside them, no amount of “clinically proven” on the front of the box changes what is inside the studies.

---

How we reviewed Amberen

We follow The HRT Index Verification Standard: we verify published prices, separate FDA-approved from compounded and from supplements, verify availability and coverage, and re-check on a fixed schedule—top providers monthly and the full roster quarterly. We evaluate on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.

We do not publish invented product scores. A number would hide the exact question that matters: whether the evidence and buying terms fit your situation.

What we actually verified

On September 2, 2026, we:

• Read the 2016 FTC settlement release and the signed 21-page federal order, then mapped the 12 current capsule-page symptom claims against the order’s symptom list.
• Separated the two underlying postmenopause capsule trials from the 2019 pooled reanalysis and from the 2024 perimenopause combination trial.
• Recorded sample size, population, setting, symptom severity, endpoint, funding, disclosed conflicts, and duration.
• Read The Menopause Society’s 2023 nonhormone position statement, including its Amberen/ammonium-succinate assessment.
• Read Alliance’s manufacturer guarantee and recorded the 60-day deadline, proof requirements, postage requirement, and marketplace-seller rules.
• Captured current prices and seller identity at Amazon and Walmart, plus the current H-E-B product and warning information.
• Compared Walmart’s direct Equate product page with the Amberen ingredient information.
• Checked the official Amberen catalog and product page for current availability, current symptom claims, the 90-day timeline, and which dosage form the gummies’ cited trial used.
• Checked current FDA information for dietary supplements, Veozah, Lynkuet, and the February 2026 menopausal hormone-therapy labeling changes.

What we did not do: We did not take Amberen, test it in a laboratory, interview the manufacturer, or pretend that retailer stars are clinical evidence. We have no relationship with Amberen or Alliance Pharma and earn nothing if you buy the supplement.

This page is editorial research. It is not medical advice and has not been reviewed by a clinician. Report an error and we will check it against the source and log the correction.

Disclosures

Affiliate disclosure: The HRT Index may earn a commission when readers start care with some telehealth providers linked on this site. We do not earn commission from Amberen or the other supplements discussed on this page. Read the full affiliate disclosure.

Supplement disclaimer: Statements about dietary supplements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent disease.

---

Amberen review: frequently asked questions

Is Amberen FDA approved?

No. It is a dietary supplement. FDA does not approve dietary supplements for safety and effectiveness before marketing in the way it approves new drugs.^[6]

Does Amberen contain hormones?

No estrogen or progesterone is listed in the product. The pooled trial reported an estradiol change from baseline, but it did not establish that Amberen works like estrogen or has a clinically meaningful hormone effect versus placebo.^[3][5]

How long does Amberen take to work?

The current product page presents changes beginning around day 30 and a full timeline through day 90. Treat those as manufacturer claims and use a baseline plus fixed checkpoints rather than memory alone.^[1]

What is the main ingredient in Amberen?

The formula is not a single-ingredient product. It is a proprietary complex that includes ammonium succinate, other succinate/fumarate salts, glycine, monosodium L-glutamate, zinc, and vitamin E.^[12]

Does Amberen contain MSG?

Yes. Monosodium L-glutamate appears in current ingredient information.^[12]

Is Amberen vegan or vegetarian?

No. Current ingredient information includes gelatin and carmine.^[12]

What is the difference between Amberen Menopause and Perimenopause?

The menopause capsules are the postmenopause succinate formula. The perimenopause product was studied as Amberen plus Smart B in a separate 2024 trial of women with mild-to-moderate perimenopausal symptoms. Do not count that trial as another test of the menopause capsules alone.^[1][4]

Can Amberen cause a period to return?

The published evidence does not establish that Amberen causes menstruation to return. Regardless of cause, any bleeding after 12 months without a period needs prompt medical evaluation.^[14]

Can I take Amberen with antidepressants or thyroid medication?

Do not guess from the words “drug free.” Current product information says to consult a clinician if you take prescription medication or have a medical condition. A pharmacist can check the specific medication list better than a general review can.^[12]

Is Amberen being discontinued?

We found no evidence of discontinuation. The official product catalog and menopause-capsule page were active, directed buyers to Amazon, and current retailer listings remained live on September 2, 2026.^{[1][10][11][12]}

Where was Amberen cheapest in the verified snapshot?

The captured Amazon 90-day offer was the lowest verified daily cost at $64.99, or about $0.72 per day. Walmart’s direct 30-day box was $24.97, or about $0.83 per day. Confirm price and seller at checkout because both can change.^[10][11]

How does the Amberen refund guarantee work?

A claim must be made within 60 calendar days of purchase. Keep the receipt and lot code, expect to pay mailing costs, and check marketplace seller eligibility. On Amazon, Alliance says the seller must be Alliance Pharma Inc.^[9]

Is Amberen better than Estroven?

No reliable head-to-head trial was located, so the evidence does not support declaring one winner. They are different supplement lines, and The Menopause Society does not recommend supplements or herbal remedies as a category for vasomotor symptoms.^[5]

Does Amberen help with weight loss?

Do not treat Amberen as a proven weight-loss product. Weight-loss, belly-fat, and metabolism claims were central to the FTC’s allegations resolved by the 2016 order, and the current controlled evidence is not a basis for promising weight loss.^[7][8]

Can you take Amberen long term?

The controlled capsule trials lasted 90 days. They do not establish long-term safety or continued benefit over years. Reassess the need, benefit, medical history, and medication list rather than continuing by default.^[3]

Is Amberen worth it?

For mild-to-moderate symptoms, a tracked 90-day trial from a verifiable seller can be reasonable. For severe or disruptive symptoms, the evidence does not cover your situation and the opportunity cost of waiting is higher.

---

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

You do not have to solve the supplement question, prescription question, and provider question at the same time. Answer a few questions about symptoms, history, preferences, coverage, and state, and get the path that fits—including the safety flag when online care is not the right starting point.

→ Use Find My HRT Path

---

Sources

¹ Amberen, Complete Menopause Symptom Relief Capsules and current product catalog, captured September 2, 2026.

² Radzinskii VE, Kuznetsova IV, Uspenskaya YB, et al. “Treatment of climacteric symptoms with an ammonium succinate-based dietary supplement: a randomized, double-blind, placebo-controlled trial.” Gynecological Endocrinology. 2016;32(sup2):64–68. DOI: 10.1080/09513590.2016.1232686.

³ Radzinsky VE, Kuznetsova IV, Uspenskaya YB, et al. “Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials.” Obstetrics and Gynecology International. 2019;2019:1572196.

⁴ Kachko VA, Shulman LP, Kuznetsova IV, et al. “Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen and Smart B in Women with Climacteric Syndrome in Perimenopause.” Advances in Therapy. 2024;41:3183–3195.

⁵ The Menopause Society. “The 2023 nonhormone therapy position statement of The North American Menopause Society.” Menopause. 2023;30(6):573–590.

⁶ U.S. Food and Drug Administration. Information for Consumers on Using Dietary Supplements.

⁷ U.S. District Court for the Central District of California. Stipulated Order for Permanent Injunction and Monetary Judgment, FTC v. Lunada Biomedical, Inc., Case No. 2:15-cv-03380-MWF-PLA, entered May 2016.

⁸ Federal Trade Commission. “Marketers of Dietary Supplement Amberen Settle FTC Charges Regarding Misleading Weight-Loss and Menopause Relief Claims.” May 20, 2016.

⁹ Alliance Pharma Inc. Satisfaction Guarantee, effective June 2024.

¹⁰ Amazon. Amberen Menopause Supplement, 90-Day Supply, price, seller, and rating capture September 2, 2026.

¹¹ Walmart. Amberen Multi-Symptom Menopause Supplement, 60 Count, price, seller, return, and rating capture September 2, 2026.

¹² H-E-B. Amberen Menopause Relief, 60 Count, ingredient, warning, and price capture September 2, 2026.

¹³ Walmart. Equate Multi-Symptom Menopause Formula Dietary Supplement, 60 Count, formula, price, and rating capture September 2, 2026.

¹⁴ American College of Obstetricians and Gynecologists. Perimenopausal Bleeding and Bleeding After Menopause.

¹⁵ U.S. Food and Drug Administration. FDA Adds Warning About Rare Occurrence of Serious Liver Injury With Use of Veozah.

¹⁶ U.S. Food and Drug Administration. Novel Drug Approvals for 2025 (Lynkuet approved October 24, 2025) and Drug Trials Snapshot: LYNKUET.

¹⁷ DailyMed. LYNKUET (elinzanetant) prescribing information, revised August 2026.

¹⁸ U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, February 12, 2026.

¹⁹ Alliance Pharma plc. Acquisition of Biogix Inc., December 2020.

²⁰ Kuznetsova IV, Uspenskaya YB, Borisova MI, et al. “Efficiency of alternative therapy in perimenopausal and postmenopausal women.” Obstetrics and Gynecology. 2016;5:126–133. (Russian-language publication.)

---

Revision log

Date	Change
September 2026	Published after re-verifying the trial count, current claims, FTC order, manufacturer guarantee, retailer pricing, seller identity, product status, ingredient warnings, and FDA-approved alternatives.

Found an error? Tell us and we will verify it against the source and log the correction.